A Taiwan patent titled "Method for treating cancer using cd14 antagonists" has been granted. 2021-05-06 Oneness received approval by TFDA on the phase 2 clinical trial application for FB704A, a fully-human anti-IL6 antibody new drug, in severe asthma. 2021-04-19 Oneness announces that Nanchou manufacturing site has been GMP and GDP certified by MOHW 2021-04-12 Oneness has submitted the phase 2 clinical trial application for FB704A, a fully-human anti-IL6 antibody new drug, in severe asthma to TFDA via fast track. 2021-04-07 An Indian patent on the Anti-CεmX (FB825) antibody was granted. 2021-04-05 Oneness was notified by US FDA today that the DFU new drug (ON101), has been granted the Fast Track Designation, which will facilitate NDA process of ON101 in US. 2021-03-31
